Acute Effect of Mometasone Furoate DPI on Beta-adrenergic Airway and Airway Vascular Relaxation in Moderately Severe Asthma.

Trial Profile

Acute Effect of Mometasone Furoate DPI on Beta-adrenergic Airway and Airway Vascular Relaxation in Moderately Severe Asthma.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jul 2016

At a glance

  • Drugs Mometasone (Primary) ; Salbutamol
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Nov 2014 The primary endpoint has been changed from airway blood flow changes to albuterol-induced change in FEV1, according to ClinicalTrials.gov record.
    • 18 Nov 2014 Status changed from not yet recruiting to completed, according to ClinicalTrials.gov record.
    • 05 Oct 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top